Mon Jun 5, 2023 – 10:23 am EDT
(LifeSiteNews) — The U.S. Food and Drug Administration (FDA) has revoked the emergency use authorization (EUA) of the Johnson & Johnson COVID vaccine.
The revocation happened officially due to the manufacturer’s own request, according to the FDA. The Johnson & Johnson (J&J) COVID inoculation is produced by its subsidiary Janssen Biotech and was authorized for emergency use on February 27, 2021.
“On May 22, 2023, Janssen Biotech, Inc. requested the voluntary withdrawal of the emergency use authorization (EUA) of the Janssen COVID-19 Vaccine,” the FDA website states.
READ: 35-year-old woman dies of brain hemorrhage 11 days after receiving J&J vaccine
“Janssen Biotech, Inc. informed the FDA that the last lots of the vaccine purchased by the U.S. Government have expired, there is no demand for new lots of the vaccine in the U.S., and they do not intend to update the strain composition of this vaccine to address emerging variants. On June 1, 2023, FDA revoked the EUA for this vaccine.”
While J&J’s EUA was officially withdrawn because all the available doses in the U.S. have expired and the pharma giant decided to discontinue the product, the FDA
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
